Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9155002 | American Heart Journal | 2005 | 7 Pages |
Abstract
Both ischemic and bleeding complications are highest in the lowest creatinine clearance quartile of patients treated with GP IIb/IIIa inhibitors. Although tirofiban is renally cleared and abciximab is not, there was no interaction between these GP IIb/IIIa inhibitors and creatinine clearance regarding ischemic or bleeding events.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter B. MD, Patricia J.M. MD, Eric J. MD, Jennifer MS, Peter M. MD, Albert W. MD, Steen D. MD, Howard C. MD, David J. MD,